PlainIndex

ETF comparison

FHLC vs IBB

Both Healthcare.

Fidelity MSCI Health Care Index ETF · iShares Biotechnology ETF

Holdings overlap

0.0 %

0 positions appear in both funds. Buying equal dollars of FHLC and IBB would leave roughly 0.0% of each dollar exposed to the same underlying securities.

FHLC only 0.0% Shared 0.0% IBB only 0.0%
In FHLC only
0 positions
Shared
0 positions
In IBB only
0 positions

Holdings data for FHLC covers 0.0% of fund weight. The remainder lacks matchable identifiers in the N-PORT filing.

Holdings data for IBB covers 0.0% of fund weight. The remainder lacks matchable identifiers in the N-PORT filing.

Side by side

FHLC

Fidelity MSCI Health Care Index ETF

Fidelity · Healthcare

84 composite / 100
Expense ratio
0.084%
Net assets
$2.85B
TTM yield
1.44%
Top-10 conc.
—
IBB

iShares Biotechnology ETF

iShares · Healthcare

74 composite / 100
Expense ratio
0.44%
Net assets
$7.95B
TTM yield
0.23%
Top-10 conc.
—

Sub-score comparison

92
Cost
56
80
Tax efficiency
85
76
Liquidity
96
N/A
Concentration
N/A
—
Tracking quality
—
FHLC sub-score IBB

Tracking-quality sub-score is not yet computed for any fund — see methodology for which inputs are live.

Cost difference

FHLC is 36 bps cheaper than IBB. On a $100,000 position that's about $356/yr more in fees for IBB.

Fee figure is the annual expense charged on $100,000. It compounds over time — we publish a fuller cost-projection calculator on the methodology page.

Top shared holdings

0 shared in total

No shared holdings between these funds.

Only in FHLC

0 total

Every FHLC position is also held by IBB.

Only in IBB

0 total

Every IBB position is also held by FHLC.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see /methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.